Topochemical examinations of the lungs of the rat after combined administration of serpasil and deslanatoside. I. Histochemical examinations.
Jedrzejewska
E A
EA
D000135:Acid Phosphatase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D002395:Catecholamines / Q000037:antagonists & inhibitors / Q000378:metabolism; D003892:Deslanoside / Q000008:administration & dosage* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007799:Lanatosides / Q000008:administration & dosage* / Q000494:pharmacology; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D012110:Reserpine / Q000008:administration & dosage* / Q000494:pharmacology; D013385:Succinate Dehydrogenase / Q000378:metabolism
D002395:Catecholamines; D007799:Lanatosides; D012110:Reserpine; D007770:L-Lactate Dehydrogenase; D013385:Succinate Dehydrogenase; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D003892:Deslanoside